Fluid balance, diuretic use, and mortality in acute kidney injury
Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients. Using data from th...
Saved in:
| Published in: | Clinical journal of the American Society of Nephrology Vol. 6; no. 5; p. 966 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.05.2011
|
| Subjects: | |
| ISSN: | 1555-905X, 1555-905X |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients.
Using data from the Fluid and Catheter Treatment Trial (FACTT), a multicenter, randomized controlled trial evaluating a conservative versus liberal fluid-management strategy in 1000 patients with acute lung injury (ALI), we evaluated the association of post-renal injury fluid balance and diuretic use with 60-day mortality in patients who developed AKI, as defined by the AKI Network criteria.
306 patients developed AKI in the first 2 study days and were included in our analysis. There were 137 in the fluid-liberal arm and 169 in the fluid-conservative arm (P=0.04). Baseline characteristics were similar between groups. Post-AKI fluid balance was significantly associated with mortality in both crude and adjusted analysis. Higher post-AKI furosemide doses had a protective effect on mortality but no significant effect after adjustment for post-AKI fluid balance. There was no threshold dose of furosemide above which mortality increased.
A positive fluid balance after AKI was strongly associated with mortality. Post-AKI diuretic therapy was associated with 60-day patient survival in FACTT patients with ALI; this effect may be mediated by fluid balance. |
|---|---|
| AbstractList | Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients.
Using data from the Fluid and Catheter Treatment Trial (FACTT), a multicenter, randomized controlled trial evaluating a conservative versus liberal fluid-management strategy in 1000 patients with acute lung injury (ALI), we evaluated the association of post-renal injury fluid balance and diuretic use with 60-day mortality in patients who developed AKI, as defined by the AKI Network criteria.
306 patients developed AKI in the first 2 study days and were included in our analysis. There were 137 in the fluid-liberal arm and 169 in the fluid-conservative arm (P=0.04). Baseline characteristics were similar between groups. Post-AKI fluid balance was significantly associated with mortality in both crude and adjusted analysis. Higher post-AKI furosemide doses had a protective effect on mortality but no significant effect after adjustment for post-AKI fluid balance. There was no threshold dose of furosemide above which mortality increased.
A positive fluid balance after AKI was strongly associated with mortality. Post-AKI diuretic therapy was associated with 60-day patient survival in FACTT patients with ALI; this effect may be mediated by fluid balance. Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients.BACKGROUND AND OBJECTIVESManagement of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients.Using data from the Fluid and Catheter Treatment Trial (FACTT), a multicenter, randomized controlled trial evaluating a conservative versus liberal fluid-management strategy in 1000 patients with acute lung injury (ALI), we evaluated the association of post-renal injury fluid balance and diuretic use with 60-day mortality in patients who developed AKI, as defined by the AKI Network criteria.DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTSUsing data from the Fluid and Catheter Treatment Trial (FACTT), a multicenter, randomized controlled trial evaluating a conservative versus liberal fluid-management strategy in 1000 patients with acute lung injury (ALI), we evaluated the association of post-renal injury fluid balance and diuretic use with 60-day mortality in patients who developed AKI, as defined by the AKI Network criteria.306 patients developed AKI in the first 2 study days and were included in our analysis. There were 137 in the fluid-liberal arm and 169 in the fluid-conservative arm (P=0.04). Baseline characteristics were similar between groups. Post-AKI fluid balance was significantly associated with mortality in both crude and adjusted analysis. Higher post-AKI furosemide doses had a protective effect on mortality but no significant effect after adjustment for post-AKI fluid balance. There was no threshold dose of furosemide above which mortality increased.RESULTS306 patients developed AKI in the first 2 study days and were included in our analysis. There were 137 in the fluid-liberal arm and 169 in the fluid-conservative arm (P=0.04). Baseline characteristics were similar between groups. Post-AKI fluid balance was significantly associated with mortality in both crude and adjusted analysis. Higher post-AKI furosemide doses had a protective effect on mortality but no significant effect after adjustment for post-AKI fluid balance. There was no threshold dose of furosemide above which mortality increased.A positive fluid balance after AKI was strongly associated with mortality. Post-AKI diuretic therapy was associated with 60-day patient survival in FACTT patients with ALI; this effect may be mediated by fluid balance.CONCLUSIONSA positive fluid balance after AKI was strongly associated with mortality. Post-AKI diuretic therapy was associated with 60-day patient survival in FACTT patients with ALI; this effect may be mediated by fluid balance. |
| Author | Brower, Roy G Grams, Morgan E Coresh, Josef Liu, Kathleen D Estrella, Michelle M |
| Author_xml | – sequence: 1 givenname: Morgan E surname: Grams fullname: Grams, Morgan E email: mgrams2@jhmi.edu organization: Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mgrams2@jhmi.edu – sequence: 2 givenname: Michelle M surname: Estrella fullname: Estrella, Michelle M – sequence: 3 givenname: Josef surname: Coresh fullname: Coresh, Josef – sequence: 4 givenname: Roy G surname: Brower fullname: Brower, Roy G – sequence: 5 givenname: Kathleen D surname: Liu fullname: Liu, Kathleen D |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21393482$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNT0tLAzEYDFKxD715lty8uDVfNtkmx1JaHxS9KHhb8vgKqfuom82h_94VKziXmYFhmJmSUdM2SMg1sDnnIO9Xzy9zphYKGLAzMgEpZaaZ_Bj902MyjXHPmBA5lxdkzCHXuVB8QpabKgVPralM4_CO-pA67IOjKQ7ONJ7WbdebKvRHGhpqXOqRfgbf4I_fp-54Sc53pop4deIZed-s31aP2fb14Wm13GZOKNZnRviF0mB3w1TURQ4oLUoJlkuO2jOnCs9BMIs77tACB2sKsDhAc6sVn5Hb395D134ljH1Zh-iwGoZjm2KpFoJBoQCG5M0pmWyNvjx0oTbdsfx7zb8BqPdaTg |
| CitedBy_id | crossref_primary_10_1186_s12882_016_0323_6 crossref_primary_10_1016_j_jfma_2021_03_004 crossref_primary_10_1111_aas_13105 crossref_primary_10_5492_wjccm_v11_i3_178 crossref_primary_10_1097_SLA_0000000000000732 crossref_primary_10_2215_CJN_06450612 crossref_primary_10_1186_cc11867 crossref_primary_10_1186_s13613_016_0145_5 crossref_primary_10_1097_MCC_0b013e32834cd334 crossref_primary_10_1371_journal_pone_0120466 crossref_primary_10_1007_s11936_012_0186_5 crossref_primary_10_1186_s13054_014_0696_5 crossref_primary_10_1007_s00431_020_03654_z crossref_primary_10_1007_s00134_021_06401_6 crossref_primary_10_1016_S1441_2772_23_01494_1 crossref_primary_10_1016_j_jcrc_2025_155016 crossref_primary_10_1007_s00134_015_3851_9 crossref_primary_10_1371_journal_pone_0224563 crossref_primary_10_1016_j_semnephrol_2018_10_001 crossref_primary_10_1016_j_semnephrol_2018_10_003 crossref_primary_10_1097_PCC_0000000000000715 crossref_primary_10_1136_bmj_k4891 crossref_primary_10_1016_j_athoracsur_2012_10_024 crossref_primary_10_1097_PCC_0000000000000720 crossref_primary_10_1016_j_kint_2018_11_047 crossref_primary_10_1016_j_jcrc_2016_03_018 crossref_primary_10_1111_apha_13357 crossref_primary_10_1016_j_ahj_2019_12_013 crossref_primary_10_1038_s41598_022_15035_7 crossref_primary_10_1155_2023_6957341 crossref_primary_10_1007_s00134_014_3360_2 crossref_primary_10_1378_chest_12_2967 crossref_primary_10_1007_s00134_019_05869_7 crossref_primary_10_1186_s13613_022_01024_6 crossref_primary_10_3390_ijms25115924 crossref_primary_10_1186_cc12372 crossref_primary_10_1186_s12882_023_03125_1 crossref_primary_10_1097_CCM_0000000000000634 crossref_primary_10_1053_j_ajkd_2013_02_349 crossref_primary_10_1097_MNH_0000000000000223 crossref_primary_10_1089_nat_2013_0438 crossref_primary_10_3389_fped_2018_00118 crossref_primary_10_1016_j_jcrc_2018_02_009 crossref_primary_10_1186_s40697_016_0099_4 crossref_primary_10_1213_ANE_0000000000006748 crossref_primary_10_1111_aas_12840 crossref_primary_10_1007_s00467_019_04314_7 crossref_primary_10_1016_j_jfma_2018_04_005 crossref_primary_10_1097_CCM_0000000000003338 crossref_primary_10_1186_s13054_019_2309_9 crossref_primary_10_2215_CJN_06420616 crossref_primary_10_1016_j_jcrc_2025_155171 crossref_primary_10_1186_s13054_020_02905_7 crossref_primary_10_1097_MCC_0b013e32835944d6 crossref_primary_10_1097_CCM_0000000000001954 crossref_primary_10_1186_s40560_015_0121_4 crossref_primary_10_1007_s00063_013_0340_1 crossref_primary_10_1007_s00108_016_0069_z crossref_primary_10_1080_03007995_2020_1840970 crossref_primary_10_1097_MCC_0b013e3283632d77 crossref_primary_10_1016_j_cjtee_2017_07_004 crossref_primary_10_1681_ASN_2014121160 crossref_primary_10_3389_fped_2020_589124 crossref_primary_10_5527_wjn_v9_i2_18 crossref_primary_10_1053_j_jvca_2015_02_004 crossref_primary_10_1016_j_jcrc_2022_154249 crossref_primary_10_1159_000533573 crossref_primary_10_1007_s12325_011_0041_1 crossref_primary_10_1016_j_ppedcard_2015_12_002 crossref_primary_10_1097_MCC_0b013e328359fdb5 crossref_primary_10_1097_MNH_0b013e3283521d95 crossref_primary_10_1097_ALN_0000000000002968 crossref_primary_10_1097_MCC_0000000000000544 crossref_primary_10_1097_CCM_0000000000004617 crossref_primary_10_1097_MCC_0b013e3283632e29 crossref_primary_10_1097_CCM_0b013e318246b9c6 crossref_primary_10_1016_j_jcrc_2019_06_031 crossref_primary_10_1097_ACO_0000000000000171 crossref_primary_10_1186_s13054_023_04357_1 crossref_primary_10_7759_cureus_66389 crossref_primary_10_1097_ACO_0000000000000055 crossref_primary_10_1371_journal_pone_0162990 crossref_primary_10_1016_j_jcrc_2024_154809 crossref_primary_10_1111_aas_13655 crossref_primary_10_1111_anae_14908 crossref_primary_10_3389_fphys_2023_1101966 crossref_primary_10_1016_j_jcrc_2011_12_017 crossref_primary_10_3389_fped_2021_722477 crossref_primary_10_1016_S0140_6736_15_60266_5 crossref_primary_10_1371_journal_pone_0228274 crossref_primary_10_1097_MCC_0b013e32835c285b crossref_primary_10_1177_1751143717699423 crossref_primary_10_1093_ckj_sfz158 crossref_primary_10_12968_bjon_2021_30_11_660 crossref_primary_10_1097_MCC_0b013e3283552af9 crossref_primary_10_1038_nrneph_2013_232 crossref_primary_10_1186_s13613_015_0095_3 crossref_primary_10_1016_j_jns_2021_117463 crossref_primary_10_1016_j_nephro_2018_10_001 crossref_primary_10_1097_MNH_0000000000000707 crossref_primary_10_3390_jcm8091396 crossref_primary_10_7759_cureus_52304 crossref_primary_10_2215_CJN_0000000000000164 crossref_primary_10_1016_j_jcrc_2016_05_012 crossref_primary_10_1038_nrneph_2011_57 crossref_primary_10_1111_aas_13557 crossref_primary_10_3389_fmed_2023_1268252 crossref_primary_10_34067_KID_0000932022 crossref_primary_10_1177_0003319720959968 crossref_primary_10_23736_S0021_9509_22_12339_6 crossref_primary_10_1177_0885066618764617 crossref_primary_10_1016_j_redare_2016_12_002 crossref_primary_10_1080_0886022X_2022_2151468 crossref_primary_10_1155_2015_148082 crossref_primary_10_2215_CJN_04750514 crossref_primary_10_1016_j_jcrc_2017_07_030 crossref_primary_10_1038_ki_2014_293 crossref_primary_10_1016_j_suc_2012_08_012 crossref_primary_10_1155_2013_792830 crossref_primary_10_1007_s00063_024_01193_1 crossref_primary_10_1097_MCC_0000000000000105 crossref_primary_10_1016_j_jcrc_2016_01_017 crossref_primary_10_1007_s10753_020_01214_z crossref_primary_10_1097_MCC_0000000000000107 crossref_primary_10_1177_0885066612465816 crossref_primary_10_1093_ndt_gfr740 crossref_primary_10_1007_s00108_017_0248_6 crossref_primary_10_1016_j_jcrc_2015_03_025 crossref_primary_10_1186_s13054_015_1085_4 crossref_primary_10_1038_ki_2014_299 crossref_primary_10_1038_s41598_019_47939_2 crossref_primary_10_1016_j_ccc_2018_08_009 crossref_primary_10_1002_14651858_CD014937_pub2 crossref_primary_10_1007_s40620_024_02189_y crossref_primary_10_3389_fphys_2019_00559 crossref_primary_10_34067_KID_0000402019 crossref_primary_10_1016_j_jcrc_2024_155002 crossref_primary_10_1038_ki_2013_378 crossref_primary_10_1016_j_tacc_2012_12_005 crossref_primary_10_1111_sdi_12964 crossref_primary_10_1111_sdi_12961 crossref_primary_10_1038_s41598_024_77981_8 crossref_primary_10_1177_08850666251345408 crossref_primary_10_1186_s40001_025_02661_w crossref_primary_10_3389_fped_2020_564902 crossref_primary_10_1016_j_jcrc_2013_07_056 crossref_primary_10_1097_TP_0000000000001738 crossref_primary_10_1016_j_ccc_2015_06_003 crossref_primary_10_1016_j_cct_2019_06_020 crossref_primary_10_1097_MD_0000000000004987 crossref_primary_10_1513_AnnalsATS_201504_187OC crossref_primary_10_1186_cc11682 crossref_primary_10_1016_j_accpm_2016_03_004 crossref_primary_10_1038_s41598_024_79533_6 crossref_primary_10_3389_fvets_2021_659960 crossref_primary_10_1053_j_ackd_2012_10_001 crossref_primary_10_1111_tmi_12313_2 crossref_primary_10_3390_ijms18081662 crossref_primary_10_1038_nrneph_2013_282 crossref_primary_10_1016_j_ccc_2015_06_013 crossref_primary_10_1186_s13054_015_1084_5 crossref_primary_10_12688_f1000research_7348_1 crossref_primary_10_1016_j_ccc_2015_06_012 crossref_primary_10_1186_s12872_020_01727_3 crossref_primary_10_1111_sdi_12978 crossref_primary_10_1097_CCE_0000000000000021 crossref_primary_10_1007_s00467_013_2427_6 crossref_primary_10_1186_s12887_018_1188_6 crossref_primary_10_1155_2021_8884438 crossref_primary_10_1097_01_mnh_0000441150_17202_be crossref_primary_10_1097_MCC_0000000000000214 crossref_primary_10_1007_s00063_014_0404_x crossref_primary_10_1016_j_amjmed_2012_08_019 crossref_primary_10_1136_bmjopen_2020_048286 crossref_primary_10_1007_s40140_019_00325_0 crossref_primary_10_1007_s11908_012_0274_4 crossref_primary_10_1111_anae_13313 crossref_primary_10_1016_j_ccm_2016_01_012 crossref_primary_10_1097_MCC_0000000000000222 crossref_primary_10_1186_s40001_023_01306_0 crossref_primary_10_1007_s00063_020_00659_2 crossref_primary_10_1186_s13054_020_2798_6 crossref_primary_10_1186_s12872_021_01879_w crossref_primary_10_4103_0972_5229_173682 crossref_primary_10_1016_j_ccc_2020_11_001 crossref_primary_10_1097_MCC_0b013e32835a1c44 crossref_primary_10_1371_journal_pone_0196088 crossref_primary_10_3390_ijms24108768 crossref_primary_10_1016_j_ajem_2014_12_013 crossref_primary_10_1111_sdi_12753 crossref_primary_10_1111_aas_14121 crossref_primary_10_1007_s00134_016_4404_6 crossref_primary_10_2215_CJN_02780314 crossref_primary_10_12788_jhm_3105 crossref_primary_10_2215_CJN_09630818 crossref_primary_10_1016_j_cqn_2016_04_006 crossref_primary_10_1186_cc13578 crossref_primary_10_1186_s12882_016_0318_3 crossref_primary_10_1016_j_athoracsur_2019_09_068 crossref_primary_10_1093_ndt_gfac269 crossref_primary_10_1681_ASN_2015060613 crossref_primary_10_1097_MCC_0000000000000039 crossref_primary_10_1186_cc12484 crossref_primary_10_1016_j_amjms_2024_07_018 crossref_primary_10_1159_000441981 crossref_primary_10_1016_j_ijcard_2019_04_083 crossref_primary_10_1097_CRD_0000000000000364 crossref_primary_10_3390_pharmaceutics14010011 crossref_primary_10_3389_fphar_2017_00499 crossref_primary_10_1371_journal_pone_0172137 crossref_primary_10_1093_bja_aeu299 crossref_primary_10_1186_s13054_016_1355_9 crossref_primary_10_1093_bja_aeu297 crossref_primary_10_1097_ACO_0b013e32834decd7 crossref_primary_10_1038_s41581_018_0044_0 crossref_primary_10_1016_j_jfma_2021_08_005 crossref_primary_10_1053_j_ackd_2016_02_007 crossref_primary_10_1007_s00101_016_0259_z crossref_primary_10_1016_j_ogc_2016_07_007 crossref_primary_10_1093_ndt_gfs375 crossref_primary_10_1371_journal_pone_0181848 crossref_primary_10_3390_jcm14062067 crossref_primary_10_1177_20552076241311173 crossref_primary_10_1097_CCM_0b013e3182978f91 crossref_primary_10_1186_s13643_015_0150_z crossref_primary_10_1016_j_semnephrol_2011_11_016 crossref_primary_10_3390_jcm11133665 crossref_primary_10_1097_CCM_0b013e31824e1a1f crossref_primary_10_1136_bmjopen_2023_074046 crossref_primary_10_1056_NEJMc1707248 crossref_primary_10_1186_cc11253 crossref_primary_10_1097_CCM_0000000000001518 crossref_primary_10_1186_cc13557 crossref_primary_10_1016_j_kint_2025_02_003 crossref_primary_10_1080_0886022X_2022_2072338 crossref_primary_10_1186_s13613_019_0557_0 crossref_primary_10_5492_wjccm_v1_i3_61 crossref_primary_10_1038_nrneph_2013_80 crossref_primary_10_1080_08998280_2020_1754700 crossref_primary_10_34067_KID_0000000692 crossref_primary_10_1177_0885066614555490 crossref_primary_10_1007_s00134_016_4573_3 crossref_primary_10_1053_j_ackd_2012_09_005 crossref_primary_10_1111_sdi_12300 crossref_primary_10_1053_j_ajkd_2019_11_010 crossref_primary_10_1186_s40560_017_0251_y crossref_primary_10_3389_fped_2018_00306 crossref_primary_10_1152_ajprenal_00130_2018 |
| ContentType | Journal Article |
| Copyright | Copyright © 2011 by the American Society of Nephrology |
| Copyright_xml | – notice: Copyright © 2011 by the American Society of Nephrology |
| CorporateAuthor | National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network |
| CorporateAuthor_xml | – name: National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.2215/CJN.08781010 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1555-905X |
| ExternalDocumentID | 21393482 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: N01-HR-46046-64 – fundername: NIDDK NIH HHS grantid: L30 DK089648 – fundername: NHLBI NIH HHS grantid: N01-HR-16146-54 – fundername: NIDDK NIH HHS grantid: T32 DK007732 – fundername: NIDDK NIH HHS grantid: T32 DK 007732-15 – fundername: NHLBI NIH HHS grantid: N01 HR016146 – fundername: NIDDK NIH HHS grantid: K23 DK081317 |
| GroupedDBID | --- 0R~ 29B 2WC 53G 5GY 5VS 6PF AAOCO AAQQT AAUIN AAWTL ABBLC ABJNI ABXYN ACLDA ACZKN ADBBV AENEX AFEXH AFNMH AHOMT AHQVU ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW BYPQX CGR CS3 CUY CVF DIK DU5 EBS ECM EIF EJD ERAAH F5P GX1 H13 HYE HZ~ KQ8 NPM O9- OK1 OVD P2P RHI RPM TEORI TNP TR2 W8F WOQ 7X8 |
| ID | FETCH-LOGICAL-c480t-a4d7891bf878e9631e5be551b252e9d0c86d2140bef2ceb121ba61beeee92b982 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 289 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000290372600005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1555-905X |
| IngestDate | Fri Jul 11 10:08:14 EDT 2025 Mon Jul 21 06:03:59 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | Copyright © 2011 by the American Society of Nephrology |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c480t-a4d7891bf878e9631e5be551b252e9d0c86d2140bef2ceb121ba61beeee92b982 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3087792 |
| PMID | 21393482 |
| PQID | 874016811 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_874016811 pubmed_primary_21393482 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-May 20110501 |
| PublicationDateYYYYMMDD | 2011-05-01 |
| PublicationDate_xml | – month: 05 year: 2011 text: 2011-May |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Clinical journal of the American Society of Nephrology |
| PublicationTitleAlternate | Clin J Am Soc Nephrol |
| PublicationYear | 2011 |
| SSID | ssj0044325 |
| Score | 2.4987607 |
| Snippet | Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 966 |
| SubjectTerms | Acute Kidney Injury - drug therapy Acute Kidney Injury - metabolism Acute Kidney Injury - mortality Acute Lung Injury - drug therapy Acute Lung Injury - metabolism Acute Lung Injury - mortality Critical Illness - mortality Critical Illness - therapy Diuretics - therapeutic use Female Fluid Therapy - methods Fluid Therapy - mortality Fluid Therapy - statistics & numerical data Furosemide - therapeutic use Humans Male Middle Aged Multicenter Studies as Topic - statistics & numerical data Proportional Hazards Models Randomized Controlled Trials as Topic - statistics & numerical data Water-Electrolyte Balance - drug effects Water-Electrolyte Balance - physiology |
| Title | Fluid balance, diuretic use, and mortality in acute kidney injury |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21393482 https://www.proquest.com/docview/874016811 |
| Volume | 6 |
| WOSCitedRecordID | wos000290372600005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-1Fe8sBIaOzm4UyoqqgQolEHkLJVfpyl8EgLafj9nJO0G2IggyUPkZyz7-4735c7Qq4xJBGhsaGH5tEFKIn0BETMs1GiGcINK21dMv8pTlORZcmk5eaULa1yaRNrQ21m2t2R9-rWcZFg7G7-6bmmUS652nbQWCedPiIZx-iKs1USIQj6dc9V9Jihl_hh1vDeOTq53vAxvfVF7Kpb-b9jy9rHjHb_ubo9stOCSzpoTsM-WYPigGyN2_T5IRmM3qvcUOXojBpuqMmr-idGWpU4k4WhHzUaR2RO84JKXS2AvuWmADd_RfEfkZfR_fPwwWt7KHg6EP7Ck4GJRcKUxY8FVDYGoQJESYqHHBLjaxEZjkGWAss12m3OlIyYAnwSrhLBj8lGMSvglFDU3Vjo0AclbMCUEtygAwSp_D63wGWX0KVspnhGXeJBFjCryulKOl1y0sh3Om9qaUw57purr3P298vnZLu50HVswwvSsaifcEk29fciL7-u6r3HMZ2MfwD1Zbgn |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fluid+balance%2C+diuretic+use%2C+and+mortality+in+acute+kidney+injury&rft.jtitle=Clinical+journal+of+the+American+Society+of+Nephrology&rft.au=Grams%2C+Morgan+E&rft.au=Estrella%2C+Michelle+M&rft.au=Coresh%2C+Josef&rft.au=Brower%2C+Roy+G&rft.date=2011-05-01&rft.issn=1555-905X&rft.eissn=1555-905X&rft.volume=6&rft.issue=5&rft.spage=966&rft_id=info:doi/10.2215%2FCJN.08781010&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1555-905X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1555-905X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1555-905X&client=summon |